Brenda J Chyla
8PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 08, 2026
Recurrent Genomic Alterations in BCRi-Experienced CLL Patients Treated With Venetoclax: Extended Phase 2 Follow-Up.Jennifer A Woyach, Relja Popovic, Emily L Rossi
|Jan 06, 2026
Analysis of Patients With Monocytic and Monocytic-Like Acute Myeloid Leukemia, Including AML-M4 and AML-M5, Treated With Venetoclax Plus Azacitidine.Marina Konopleva, Courtney D DiNardo, Yan Sun
|Feb 12, 2024
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia.Keith W Pratz, Brian A Jonas, Vinod Pullarkat
|Aug 25, 2022
Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and Azacitidine.Daniel A Pollyea, Keith W Pratz, Andrew H Wei
|Jul 18, 2022
Venetoclax Plus Gilteritinib for <i>FLT3</i>-Mutated Relapsed/Refractory Acute Myeloid Leukemia.Naval Daver, Alexander E Perl, Joseph Maly
|Jan 22, 2022
Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid Leukemia.Marina Konopleva, Michael J Thirman, Keith W Pratz
Pageof 2
Frequent Collaborators
5 joint publications
Courtney D DiNardo
2 joint publications
Daniel A Pollyea
2 joint publications
Matthew S Davids
2 joint publications
Vinod Pullarkat
2 joint publications
Yinghui Duan
2 joint publications
Catherine L Miller
2 joint publications
Hagop M Kantarjian
2 joint publications
Jacqueline S Garcia
2 joint publications
Andrew H Wei
2 joint publications
Keith W Pratz
